Blog

Patrick Hwu: I had the honor of speaking at our Graduate Medical Education graduation ceremony at Moffitt Cancer Center

Photo from Patrick Hwu/LinkedIn

Jun 15, 2024, 15:34

Patrick Hwu: I had the honor of speaking at our Graduate Medical Education graduation ceremony at Moffitt Cancer Center

Patrick Hwu posted on LinkedIn:

“Congratulations, grads!
Last night, I had the honor of attending and speaking at our Graduate Medical Education graduation ceremony at Moffitt Cancer Center. Forty-eight fellows and residents graduated, gaining invaluable experience in various program areas, from cytopathology to radiation, thoracic oncology, hematology, and more.

A residency or fellowship is an essential step in medical training, during which trainees get hands-on experience in their chosen clinical specialty. I remember my residency at Johns Hopkins Hospital and fellowship at the National Cancer Institute (NCI) like yesterday.

Please join me in congratulating this new class of Moffitt GME grads. We are so proud and know that each of them will go on to make a difference!”

No alt text provided for this image

Source: Patrick Hwu/LinkedIn

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.